CEACAM5 and neoplasm: Carcinoembryonic antigen (CEA) is a tumour marker used to monitor disease progression in non-pregnant women has little value in the pregnant population as levels are raised by pregnancy itself.50 Staging investigations should not be withheld if pregnant.